SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001401914-19-000080
Filing Date
2019-08-14
Accepted
2019-08-14 16:02:55
Documents
6
Period of Report
2019-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dare8-k.htm 8-K 26198
2 EXHIBIT 99.1 dare2q2019earningspressr.htm EX-99.1 16536
3 dare2q2019earningspressr001.jpg GRAPHIC 247507
4 dare2q2019earningspressr002.jpg GRAPHIC 334499
5 dare2q2019earningspressr003.jpg GRAPHIC 252062
6 dare2q2019earningspressr004.jpg GRAPHIC 136926
  Complete submission text file 0001401914-19-000080.txt   1381826
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36395 | Film No.: 191026137
SIC: 2834 Pharmaceutical Preparations